Photodermatitis Disease

DESCRIPTION
Light-induced eruptions seen in a pattern of photo-distribution
  • Phototoxic reactions - result of the acute toxic effect on skin of ultraviolet light alone (sunburn) or together with a photosensitizing substance (non-allergic)
  • Photoallergic eruptions - a form of allergic dermatitis resulting from combined effects of a photosensitizing substance (drugs or chemical) plus ultraviolet light (immunologic/delayed hypersensitivity)
  • Polymorphous light eruption (PLE) - chronic, intermittent light-induced eruption with erythematous papules, urticaria, or vesicles on areas exposed to sunlight
  • System(s) affected: Skin/Exocrine
  • Genetics: Predisposition occurs in inbred populations (e.g., Pima Indians)
  • Incidence/Prevalence in USA: Unknown
  • Predominant age: All ages
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Phototoxic
    • Erythema
    • With increasing severity - vesicles and bullae
    • Classic example - sunburn
    • Nails may exhibit onycholysis
    • Chronic - epidermal thickening, elastosis, telangiectasia and pigmentary changes
    • Sharp lines of demarcation between involved and uninvolved skin (sunlight exposure)
    • Phototoxic eruption due to topicals - area of application
    • Usually develops shortly after sun exposure
    • Hyperpigmentation may follow resolution
    • Pain
  • Photoallergic
    • Papules with erythema and occasionally vesicles
    • Area exposed to light with less distinct borders
    • Usually delayed - 24 hours or more after exposure
    • May spread to unexposed areas
    • Pruritus
  • Polymorphous light eruption (PLE)
    • Erythematous papules
    • Occasionally urticaria or vesicles
    • Scattered over sun exposed areas with normal skin in between
    • Can spread to non-exposed areas
    • Often flares in spring or early summer
    • Desensitization affect (less over the course of the summer)
    • Burning or pruritus may precede lesions
CAUSES
  • Sunlight
  • Phenothiazines
  • Diuretics
  • Tetracyclines
  • Sulfonamides
  • Oral contraceptives
  • Topicals - psoralens, coal tars, photo-active dyes (eosin, acridine orange)
RISK FACTORS
N/A
LABORATORY

Antinuclear antibody (ANA) to rule out systemic lupus erythematosus

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
Nonspecific
SPECIAL TESTS
  • Photo-testing
  • Photopatch testing
  • Skin biopsy - to rule out other disorders
IMAGING

N/A

DIAGNOSTIC PROCEDURES
Physical examination and medical history
APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Avoid sunlight/limit exposure
  • Protective clothing/sunscreens
  • Ice packs/cold water compresses
SURGICAL MEASURES

N/A

ACTIVITY

Avoid sunlight

DIET

No special diet

PATIENT EDUCATION
  • Avoidance of sunlight
  • Avoidance of photosensitizing drugs
  • Protective clothing
  • Sunscreens
PREVENTION/AVOIDANCE
  • Sunlight avoidance/protective clothing
  • Identification and avoidance of causative drugs (see under Causes)
  • Sunscreens - apply before exposure
    • Zinc oxide - opaque, cosmetically less acceptable
    • Chemical - use sun-protective factor > 15 for maximum protection; substantively resistant to sweat and swimming; cosmetically more acceptable
POSSIBLE COMPLICATIONS

N/A

EXPECTED COURSE AND PROGNOSIS

Good with avoidance/protection measures

ASSOCIATED CONDITIONS
  • Sunlight aggravation of systemic lupus
  • Persistent light reactivity
  • Actinic reticuloid
AGE-RELATED FACTORS

N/A

Pediatric: N/A
Geriatric: More likely to experience adverse reactions to causative drugs
Others: N/A

PREGNANCY

N/A

OTHER NOTES

N/A

ABBREVIATIONS

NSAID = nonsteroidal anti-inflammatory drugs

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.